Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2100528	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	License Renew	2021-04-23					view
JYHZ2100527	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	License Renew	2021-04-23					view
JYHZ2100526	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	License Renew	2021-04-23					view
JYHZ2100525	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	License Renew	2021-04-23					view
JYHF1800015	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2018-02-07	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2018-03-06	view
JYHF1800014	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2018-02-07	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2018-03-06	view
JYHB2400369	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2024-07-17		AstraZeneca AB			view
JYHB2400368	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2024-07-17		AstraZeneca AB			view
JYHB2400005	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2024-01-04		AstraZeneca AB			view
JYHB2400004	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2024-01-04		AstraZeneca AB			view
JYHB2300486	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2023-08-29		AstraZeneca AB			view
JYHB2300485	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2023-08-29		AstraZeneca AB			view
JYHB2300132	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2023-02-21		AstraZeneca AB			view
JYHB2300131	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2023-02-21		AstraZeneca AB			view
JYHB2101572	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-12-09		AstraZeneca AB			view
JYHB2101571	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-12-09		AstraZeneca AB			view
JYHB2100141	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-02-20	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2021-09-23	view
JYHB2100140	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-02-20	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2021-09-23	view
JYHB2002229	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2020-11-05	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Filed	2020-11-24	view
JYHB2002228	甲磺酸奥希替尼片	osimertinib mesylate	Tablet	Chemical Drugs	Supplementary Application	2020-11-05	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Filed	2020-11-24	view